Evidence map›Paper›PMID 27168765›Full record

ArticleBioData mining2016

Identification of genetic interaction networks via an evolutionary algorithm evolved Bayesian network.

Ruowang Li, Scott M Dudek, Dokyoon Kim, Molly A Hall, Yuki Bradford, Peggy L Peissig, Murray H Brilliant, James G Linneman, Catherine A McCarty, Le Bao and 1 more

Open access · goldAbstract read
In one paragraph

Article in BioData mining, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Analysis of high-resolution 3D intrachromosomal interactions aided by Bayesian network modeling.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  7. New Algorithm and Software (BNOmics) for Inferring and Visualizing Bayesian Networks from Heterogeneous Big Biological and Genetic Data.Journal of computational biology : a journal of computational molecular cell biology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ruowang LiCenter for Systems Genomics, Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
Scott M DudekCenter for Systems Genomics, Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
Dokyoon KimCenter for Systems Genomics, Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
Molly A HallCenter for Systems Genomics, Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
Yuki BradfordCenter for Systems Genomics, Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
Peggy L PeissigBiomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin USA.
Murray H BrilliantBiomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin USA.
James G LinnemanBiomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin USA.
Catherine A McCartyEssentia Rural Health, Duluth, Minnesota USA.
Le BaoDepartment of Statistics, Pennsylvania State University, University Park, Pennsylvania, USA.
Marylyn D RitchieCenter for Systems Genomics, Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA ; Biomedical & Translational Informatics, Geisinger Health System, Danville, Pennsylvania USA.
Pennsylvania State University · USMarshfield Clinic · USEssentia Health · USGeisinger Health System · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
Pharmacogenomics of Statin TherapyP50GM115318 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAUSS, RONALD M, LUSIS, ALDONS JAKE · 2015 to 2019
$14.0M
IRIS: Incorporating Research Into SightU01HG006389 · NHGRI · ESSENTIA INSTITUTE OF RURAL HEALTH · PI MCCARTY, CATHERINE ANNE · 2011 to 2014
$4.1M
Novel methods to identify and replicate complex interactions in common diseaseF31HG008588 · NHGRI · PENNSYLVANIA STATE UNIVERSITY, THE · PI HALL, MOLLY ANN · 2015 to 2015
$9k
NCATS NIH HHS UL1 TR000427NHGRI NIH HHS F31 HG008588NHGRI NIH HHS U01 HG006389NIGMS NIH HHS P50 GM115318
6 · The paper itself

Abstract

backgroundThe future of medicine is moving towards the phase of precision medicine, with the goal to prevent and treat diseases by taking inter-individual variability into account. A large part of the variability lies in our genetic makeup. With the fast paced improvement of high-throughput methods for genome sequencing, a tremendous amount of genetics data have already been generated. The next hurdle for precision medicine is to have sufficient computational tools for analyzing large sets of data. Genome-Wide Association Studies (GWAS) have been the primary method to assess the relationship between single nucleotide polymorphisms (SNPs) and disease traits. While GWAS is sufficient in finding individual SNPs with strong main effects, it does not capture potential interactions among multiple SNPs. In many traits, a large proportion of variation remain unexplained by using main effects alone, leaving the door open for exploring the role of genetic interactions. However, identifying genetic interactions in large-scale genomics data poses a challenge even for modern computing.

resultsFor this study, we present a new algorithm, Grammatical Evolution Bayesian Network (GEBN) that utilizes Bayesian Networks to identify interactions in the data, and at the same time, uses an evolutionary algorithm to reduce the computational cost associated with network optimization. GEBN excelled in simulation studies where the data contained main effects and interaction effects. We also applied GEBN to a Type 2 diabetes (T2D) dataset obtained from the Marshfield Personalized Medicine Research Project (PMRP). We were able to identify genetic interactions for T2D cases and controls and use information from those interactions to classify T2D samples. We obtained an average testing area under the curve (AUC) of 86.8 %. We also identified several interacting genes such as INADL and LPP that are known to be associated with T2D.

conclusionsDeveloping the computational tools to explore genetic associations beyond main effects remains a critically important challenge in human genetics. Methods, such as GEBN, demonstrate the utility of considering genetic interactions, as they likely explain some of the missing heritability.

Indexed as

Bayesian NetworkDiscriminant analysisEvolution algorithmGenetic interactionsType 2 diabetes

Identifiers

PMID27168765
PMCPMC4862166
OpenAlexW2347008592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.